Viewing Study NCT03903705


Ignite Creation Date: 2025-12-25 @ 3:20 AM
Ignite Modification Date: 2026-03-01 @ 6:03 AM
Study NCT ID: NCT03903705
Status: COMPLETED
Last Update Posted: 2025-04-06
First Post: 2019-03-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: : A Phase Ib/II Study To Evaluate Fruquintinib Monotherapy Or Plus Sintilimab In Advanced Solid Tumors
Sponsor: Hutchmed
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module